z-logo
open-access-imgOpen Access
Generation of Novel Anti-MUC1 Monoclonal Antibodies with Designed Carbohydrate Specificities Using MUC1 Glycopeptide Library
Author(s) -
Shoichi Naito,
Tatsuya Takahashi,
Junji Onoda,
Shoko Uemura,
Naoki Ohyabu,
Hiroshi Takemoto,
Shoji Yamane,
Ikuo Fujii,
ShinIchiro Nishimura,
Yoshito Numata
Publication year - 2017
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.7b00708
Subject(s) - glycan , epitope , muc1 , monoclonal antibody , glycopeptide , glycosylation , antibody , chemistry , glycoprotein , mucin , biochemistry , microbiology and biotechnology , biology , immunology , antibiotics
Numerous anti-mucin 1 (anti-MUC1) antibodies that recognize O -glycan core structures have already been developed. However, most of them show low specificities toward O -glycan structures and/or low affinity toward a monovalent epitope. In this study, using an MUC1 glycopeptide library, we established two novel anti-MUC1 monoclonal antibodies (1B2 and 12D10) with designed carbohydrate specificities. Compared with previously reported anti-MUC1 antibodies, 1B2 and 12D10 showed quite different features regarding their specificities, affinities, and reactivity profiles to various cell lines. Both antibodies recognized specific O -glycan structures at the PDT*R motif (the asterisk represents an O -glycosylation site). 1B2 recognized O -glycans with an unsubstituted O -6 position of the GalNAc residue (Tn, T, and 23ST), whereas 12D10 recognized Neu5Ac at the same position (STn, 26ST, and dST). Neither of them bound to glycopeptides with core 2 O -glycans that have GlcNAc at the O -6 position of the GalNAc residue. Furthermore, 1B2 and 12D10 showed a strong binding to not only native MUC1 but also 20-mer glycopeptide with a monovalent epitope. These anti-MUC1 antibodies should thus become powerful tools for biological studies on MUC1 O -glycan structures. Furthermore, the strategy of using glycopeptide libraries should enable the development of novel antibodies with predesigned O -glycan specificities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom